RN

Rihana Nisar Patel

Active Director Director DIN 10646043
DIN 10646043 First appointment May 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rihana Nisar Patel

Data last updated:

Rihana Nisar Patel is a Director at Dolphinne Hospital And Iccu Private Limited (since 2024). The company operates in Healthcare.

DIN 10646043
Primary Designation Director
Industry Healthcare
First Appointment 28 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 May 20242024Active

Directorship timeline

Open interactive timeline →
Dolphinne Hospital And Iccu Private Limited
Premium access

Shareholding and investment profile for Rihana Nisar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rihana Nisar Patel

Rihana Nisar Patel currently holds 1 directorship: Dolphinne Hospital And Iccu Private Limited (Director, since 28 May 2024).

Rihana Nisar Patel was first appointed on 28 May 2024 as Director at Dolphinne Hospital And Iccu Private Limited.

The current boards of Rihana Nisar Patel's companies include Asad Ali Nisar Patel (Dolphinne Hospital And Iccu Private Limited), Javed Mohammed Ali Firfiray (Dolphinne Hospital And Iccu Private Limited), Nisar Moinuddin Patel (Dolphinne Hospital And Iccu Private Limited), Saba Nisar Patel (Dolphinne Hospital And Iccu Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available